ADCT News and Press, ADC Therapeutics SA From 08/12/25

2025-08-12 07:34:06 ET More on ADC Therapeutics ADC Therapeutics SA (ADCT) Q1 2025 Earnings Call Transcript ADC Therapeutics SA 2025 Q1 - Results - Earnings Call Presentation ADC reports data from lymphoma trial, streamlines operations ADC Therapeutics announ...

ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update PR Newswire ZYNLONTA® in combination with glofitamab (COLUMVI®) demonstrated overall response rate (ORR) of 93.3% and a complete response (CR) rate of 86.7% in LOTIS-7 ...

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 PR Newswire LAUSANNE , Switzerland , Aug. 5, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of ...

SOPHiA GENETICS SA (SOPH) is expected to report for Q2 2025 Investors Title Company (ITIC) is expected to report for Q2 2025 Safehold Inc. (SAFE) is expected to report $0.39 for Q2 2025 First Guaranty Bancshares Inc. (FGBI) is expected to report $-0.2 for Q2 2025 United Fire Group...

ADC Therapeutics SA (ADCT) is expected to report $-0.36 for Q2 2025

ADC Therapeutics Makes Grant to New Employee Under Inducement Plan PR Newswire LAUSANNE , Switzerland , July 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs)...

2025-06-30 17:36:52 ET More on ADC Therapeutics ADC reports data from lymphoma trial, streamlines operations ADC Therapeutics announces $100M private financing Seeking Alpha’s Quant Rating on ADC Therapeutics Read the full article on Seeking Alpha ...

2025-06-26 10:27:47 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – With analysts forecasting the global oncology drug market to surpass US$900 billion by 2034, investor interest in cancer-focus...

2025-06-26 09:59:46 ET Issued on behalf of Oncolytics Biotech Inc. Vancouver, BC – June 26, 2025  – USA News Group News Commentary – With analysts forecasting the global oncology drug market to surpass US$900 billion by 2034,...